BCL6, DUSP3, and IL6R Are Identified as Shared Druggable Immune-Regulatory Axis in Atrial Fibrillation and Atherosclerosis Through Integrative In Silico and In Vitro Analysis.

Hum Mutat · 2025 · PMC12626707 · PMID 41262879

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

Most other immune subsets, such as MAIT cells, effector memory T cells, and macrophages, showed distributional shifts that failed to reach statistical significance after FDR correction.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

&lt;i&gt;BCL6&lt;/i&gt;, &lt;i&gt;DUSP3&lt;/i&gt;, and &lt;i&gt;IL6R&lt;/i&gt; Are Identified as Shared Druggable Immune-Regulatory Axis in Atrial Fibrillation and Atherosclerosis Through Integrative In Silico and In Vitro Analysis.

The sentences

<i>BCL6</i>, <i>DUSP3</i>, and <i>IL6R</i> Are Identified as Shared Druggable Immune-Regulatory Axis in Atrial Fibrillation and Atherosclerosis Through Integrative In Silico and In Vitro Analysis.